-
Oxford-based Argive develops rapid 3D-printed microturbines in Oxford
Oxford-based Argive has developed two 3D-printed microturbines, cutting production time to 10 weeks. Following successful tests, the innovation strengthens UK manufacturing sovereignty, offering faster, lighter, and more efficient propulsion systems for defence, drones, and other critical applications.
-
Harrow Estates secures 300-acre site for landmark Bicester development
Harrow Estates has acquired a 300-acre site in Bicester to deliver 1,500 homes, a 21-hectare Nature Conservation Area, and new community facilities, with works starting in 2027 on what will become a flagship, nature-led Oxfordshire development.
-
Construction begins on Aspen Building at Wood Centre for Innovation in Headington
The Oxford Trust has broken ground on its Aspen Building at the Wood Centre for Innovation. The new facility will provide laboratory and office space, boost jobs, and expand Science Oxford’s STEM outreach when it opens in summer 2026.
-
Beard partners with Abingdon & Witney College to support future construction talent
Beard Construction has joined forces with Abingdon & Witney College to provide Oxfordshire students with valuable on-site experience as part of the T-Level Technical Qualification in Design, Surveying and Planning for Construction.
-
Greyarc Investments unveils plans for redevelopment of Building 2700 into OxBio Hub
Greyarc Investments has revealed plans to transform Oxford Business Park’s former Oxfam HQ into OxBio Hub, a flexible, sustainable innovation campus designed for science and technology companies, providing lab-ready spaces, modern amenities and growth opportunities.
-
Moa signs partnership with Gowan to develop groundbreaking weed control
Moa Technology has discovered amplifier molecules that could reduce herbicide use worldwide. With Gowan as its first partner, the breakthrough marks the start of a new, sustainable category of crop protection.
-
OrganOx delivers record returns for BGF with landmark $1.5bn MedTech valuation exit
Oxford’s OrganOx has been acquired in a landmark $1.5bn deal, delivering BGF’s biggest-ever return and cementing its status as one of the UK’s largest MedTech exits to date.









